Skip to main content
. 2015 Aug 18;10(8):e0135829. doi: 10.1371/journal.pone.0135829

Fig 3. Platinum-containing chemotherapy regimens combined with EGFR TKIs vs. chemotherapy group (A) OS. (B) ORR.

Fig 3